BioSpace News Archive

- Poster Presentation to go Live on October 7, 2021 at 9 a.m. ET and on Demand at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced today, the publication of new preclinical data in the journal Nature showing that an early-stage compound with a novel mechanism of action could potentially treat all serotypes of dengue fever and provide a period of protection against acquiring the dengue virus.

MSU Health Care now offers remote monitoring to patients with health conditions like diabetes, hypertension, obesity, high cholesterol and heart disease through a partnership with Higi Care Everyday, powered by Assure Health.

Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia™ Drug-Eluting Vascular Stent System (Eluvia stent) during a late-breaking clinical trial presentation at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.

Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy to treat severely calcified cardiovascular disease, announced that an interim analysis from the Disrupt PAD III Observational Study showed that IVL performs consistently well across challenging peripheral vessels, lesions and patients.

Biomedical engineers and surgeons at UCLA and Duke University have developed an antibiotic coating that can be applied to orthopedic implants during surgery to eliminate the chance of an infection around the implant.

Micro-Tech Endoscopy USA seeks to improve oxygenation during endoscopic procedures with its newest invention, Breathe-EZ Bite Block.

Denali Therapeutics Inc. (NASDAQ: DNLI), today announced positive Phase 1 clinical results and regulatory progress for two investigational small molecule therapeutics in development for the treatment of amyotrophic lateral sclerosis (ALS) at the 2021 Annual Northeast ALS (NEALS) Meeting.

Centogene N.V. and Twist Bioscience Corporation announced today that they have signed a contract to collaborate on the development and commercialization of custom assay kits for rare diseases.

NEXGEL, Inc. (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced positive results from its validation study, demonstrating the antimicrobial properties of its SilverSeal® product line.